Dr Anne Portwich is a Partner of LSP and has been with the firm since 2001. She has served on the Board of Directors for iSTAR Medical since 2019.
Anne Portwich, PhD, is a Partner of LSP, an independent European investment firm, providing financing for private and public life sciences and healthcare companies. With over €2.7 billion capital raised and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s leading life sciences investor. Anne currently serves on the supervisory boards of Atlantic Therapeutics, MedEye, ViCentra, OneProjects and Vivasure Medical. Previous board positions include Sapiens Steering Brain Stimulation (acquired by Medtronic in 2014), ActoGeniX (acquired by Intrexon in 2015), Nexstim (IPO in 2014) and Neuravi (acquired by Codman Neuro in 2017). Prior to joining LSP, Anne was a scientist and project leader at OctoPlus, a Dutch company offering advanced research services to pharmaceutical and biotechnology companies. She obtained an MSc in biochemistry from the University of Hanover and received her PhD from the Max Planck-Society.